Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide

European Journal of Immunology

Volumn 36, Issue 7, 2006, Pages 1805-1814

  Appay, Victor ^a,b   Speiser, Daniel E ^a   Rufer, Nathalie ^c   Reynard, Severine ^a   Barbey, Catherine ^a   Cerottini, Jean Charles ^a   Leyvraz, Serge ^a   Pinilla, Clemencia ^d   Romero, Pedro ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b Laboratoire d'Immunologie Cellulaire et Tissulaire CNRS URA 625   (France)

^c SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^d TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

Antigens; Human; T cells; Vaccination

Indexed keywords

CPG ODN 7909; CPG OLIGODEOXYNUCLEOTIDE; FREUND ADJUVANT; HLA A2 ANTIGEN; MELAN A; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VAXIMMUNE;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ARTICLE; CANCER PATIENT; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; COMBINATORIAL LIBRARY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS REACTION; EX VIVO STUDY; HUMAN; HUMAN CELL; IN VIVO STUDY; LYMPHOCYTE CLONE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MELANOMA; MEMORY T LYMPHOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

ANTIGENS, NEOPLASM; CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS-PRIMING; EPITOPES, T-LYMPHOCYTE; HUMANS; MELANOMA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; VACCINES, SUBUNIT;

EID: 33746238534     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535805     Document Type: Article

References (31)

1. Hedrick, S. M., Matis, L. A., Hecht, T. T., Samelson, L. E., Longo, D. L., Heber-Katz, E. and Schwartz, R. H., The fine specificity of antigen and Ia determinant recognition by T cell hybridoma clones specific for pigeon cytodhrome c. Cell 1982. 30: 141-152.
2. Carbone, F. R., Fox, B. S., Schwartz, R. H. and Paterson, Y., The use of hydrophobic, alpha-helix-defined peptides in delineating the T cell determinant for pigeon cytochrome c. J. Immunol. 1987. 138: 1838-1844.
3. Gotch, F., McMichael, A. and Rothbard, J., Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site. J. Exp. Med. 1988. 168: 2045-2057.
4. Burrows, S. R., Silins, S. L., Moss, D. J., Khanna, R., Misko, I. S. and Argaet, V. P., T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen. J. Exp. Med. 1995. 182: 1703-1715.
5. Hausmann, S., Biddison, W. E., Smith, K. J., Ding, Y. H., Garboczi, D. N., Utz, U., Wiley, D. C. and Wucherpfennig, K. W., Peptide recognition by two HLA-A2/Tax11-19-specific T cell clones in relationship to their MHC/peptide/TCR crystal structures. J. Immunol. 1999. 162: 5389-5397.
6. Baker, B. M., Gagnon, S. J., Biddison, W. E. and Wiley, D. C., Conversion of a T cell antagonist into an agonist by repairing a defect in the TCR/peptide/MHC interface: Implications for TCR signaling. Immunity 2000. 13: 475-484.
7. Huesmann, M., Scott, B., Kisielow, P. and von Boehmer, H., Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell 1991. 66: 533-540.
8. Ignatowicz, L., Kappler, J. and Marrack, P., The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 1996. 84: 521-529.
9. Burrows, S. R., Silins, S. L., Khanna, R., Burrows, J. M., Rischmueller, M., McCluskey, J. and Moss, D. J., Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: Degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur. J. Immunol. 1997. 27: 1726-1736.
10. Lang, H. L., Jacobsen, H., Ikemizu, S., Andersson, C., Harlos, K., Madsen, L., Hjorth, P. et al., A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat. Immunol. 2002. 3: 940-943.
11. Lee, J. K., Stewart-Jones, G., Dong, T., Harlos, K., Di Gleria, K., Dorrell, L., Douek, D. C. et al., T cell cross-reactivity and conformational changes during TCR engagement. J. Exp. Med. 2004. 200: 1455-1466.
12. Mason, D., A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 1998. 19: 395-404.
13. + T-cell approach feasible? Nat. Rev. Immunol. 2002. 2: 283-291.
14. Selin, L. K. and Welsh, R. M., Plasticity of T cell memory responses to viruses. Immunity 2004. 20: 5-16.
15. + T cell responses to vaccination with peptide, IFA, and CpG oligodeoxynucleotide 7909. J. Clin. Invest. 2005. 115: 739-746.
16. Zippelius, A., Pittet, M. J., Batard, P., Rufer, N., de Smedt, M., Guillaume, P., Ellefsen, K. et al., Thymic selection generates a large T cell pool recognizing a self-peptide in humans. J. Exp. Med. 2002. 195: 485-494.
17. Dutoit, V., Rubio-Godoy, V., Pittet, M. J., Zippelius, A., Dietrich, P. Y., Legal, F. A., Guillaume, P. et al., Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/ Melan-A peptide multimer(+) CD8(+) T cells in humans. J. Exp. Med. 2002. 196: 207-216.
18. Rubio-Godoy, V., Dutoit, V., Zhao, Y., Simon, R., Guillaume, P., Houghten, R., Romero, P. et al., Positional scanning-synthetic peptide library-based analysis of self- and pathogen-derived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL. J. Immunol. 2002. 169: 5696-5707.
19. Romero, P., Valmori, D., Pittet, M. J., Zippelius, A., Rimoldi, D., Levy, F., Dutoit, V. et al., Antigenicity and immunogenicity of Melan-A/ MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol. Rev. 2002. 188: 81-96.
20. Stuge, T. B., Holmes, S. P., Saharan, S., Tuettenberg, A., Roederer, M., Weber, J. S. and Lee, P. P., Diversity and recognition efficiency of T cell responses to cancer. PLoS Med. 2004. 1: e28.
21. Pinilla, C., Rubio-Godoy, V., Dutoit, V., Guillaume, P., Simon, R., Zhao, Y., Houghten, R. A. et al., Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes. Cancer Res. 2001. 61: 5153-5160.
22. Dooley, C. T. and Houghten, R. A., The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands. Life Sci. 1993. 52: 1509-1517.
23. Eichler, J., Lucka, A. W. and Houghten, R. A., Cyclic peptide template combinatorial libraries: Synthesis and identification of chymotrypsin inhibitors. Pept. Res. 1994. 7: 300-307.
24. Pinilia, C., Martin, R., Gran, B., Appel, J. R., Boggiano, C., Wilson, D. B. and Houghten, R. A., Exploring immunological specificity using synthetic peptide combinatorial libraries. Curr. Opin. Immunol. 1999. 11: 193-202.
25. Rubio-Godoy, V., Ayyoub, M., Dutoit, V., Servis, C., Schink A., Rimoldi, D., Romero, P. et al., Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity. Eur. J. Immunol. 2002. 32: 2292-2299.
26. Tumenjargal, S., Gellrich, S., Linnemann, T., Muche, J. M., Lukowsky, A., Audring, H., Wiesmuller, K. H. et al., Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope. Eur. J. Immunol. 2003. 33: 3175-3185.
27. Zhao, Y., Gran, B., Pinilla, C., Markovic-Plese, S., Hemmer, B., Tzou, A., Whitney, L. W. et al., Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J. Immunol. 2001. 167: 2130-2141.
28. Papagno, L., Spina, C. A., Marchant, A., Salio, M., Rufer, N., Little, S., Dong, T. et al., Immune activation and CD8(+) T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004. 2: E20.
29. Gamadia, L. E., van Leeuwen, E. M., Remmerswaal, E. B., Yong, S. L., Surachno, S., Wertheim-van Dillen, P. M., Ten Berge, I. J. and Van Lier, R. A., The size and phenotype of virus-specific T cell populations is determined by repetitive antigenic stimulation and environmental cytokines. J. Immunol. 2004. 172: 6107-6114.
30. + memory T cells. J. Exp. Med. 1997. 186: 859-865.
31. Romero, P., Dunbar, P. R., Valmori, D., Pittet, M., Ogg, G. S., Rimoldi, D., Chen, J. L. et al., Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J. Exp. Med. 1998. 188: 1641-1650.